Article Details

XellSmart Completed World's First Patient Dosing in its Registrational Clinical trial for iPSC ...

Retrieved on: 2025-07-28 14:12:22

Tags for this article:

Click the tags to see associated articles and topics

XellSmart Completed World's First Patient Dosing in its Registrational Clinical trial for iPSC .... View article details on hiswai:

Excerpt

... Sequoia Capital China (Hongshan), and others. For funding and BD cooperation, please contact: BD@xellsmart.com · Support Us. MOST READ. Taiwan receipt ...

Article found on: www.taiwannews.com.tw

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo